Hong Kong Baptist University (HKBU) has taken a strategic approach to the research and development of drugs based on traditional Chinese Herbal Medicine (CHM) with the establishment of the Centre for Chinese Herbal Medicine Drug Development in the Health@InnoHK cluster (The Centre). For years, the University has been focusing on the translation of Chinese medicinal wisdom into pharmaceutical products using cutting-edge technology. The Centre will serve as a strategic platform for HKBU researchers to join forces with renowned global partners and expand the range of CHM-based drugs. It will achieve this goal by enhancing the quality of preclinical and clinical CHM research and transforming the results into pharmaceutical products for international markets.
The Centre has three main missions:
- ● To develop a CHM drug development platform. Each component of the platform could either work together as the pipeline for CHM-based new drug development or work separately for a specific CHM formula related preclinical or clinical studies.
- ● To develop CHM-based new pharmaceutical drugs based on the requirements of the NMPA in China, the Chinese Medicine Council of Hong Kong and the US FDA, targeting the market needs, with the CHM formulas that are supported by evidence-based pre-clinical and clinical researches.
- ● To nurture talents for CHM research in Hong Kong.
Applications are invited for the following posts in the Centre for Chinese Herbal Medicine Drug Development, which is located in the Hong Kong Science Park.